Cargando…
T Cell-Mediated Immune Responses to AAV and AAV Vectors
Adeno-associated virus (AAV)-mediated gene transfer has benefited patients with inherited diseases, such as hemophilia B, by achieving long-term expression of the therapeutic transgene. Nevertheless, challenges remain due to rejection of AAV-transduced cells, which in some, but not all, patients can...
Autor principal: | Ertl, Hildegund C. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076552/ https://www.ncbi.nlm.nih.gov/pubmed/33927727 http://dx.doi.org/10.3389/fimmu.2021.666666 |
Ejemplares similares
-
Immunogenicity and toxicity of AAV gene therapy
por: Ertl, Hildegund C. J.
Publicado: (2022) -
Cell-Mediated Immunity to AAV Vectors, Evolving Concepts and Potential Solutions
por: Basner-Tschakarjan, Etiena, et al.
Publicado: (2014) -
Human Immune Responses to Adeno-Associated Virus (AAV) Vectors
por: Ronzitti, Giuseppe, et al.
Publicado: (2020) -
Role of the vector genome and underlying factor IX mutation in immune responses to AAV gene therapy for hemophilia B
por: Rogers, Geoffrey L, et al.
Publicado: (2014) -
Humoral Immune Response to AAV
por: Calcedo, Roberto, et al.
Publicado: (2013)